Sign Up | Log In | What is SocialPicks?

6 pts

Opinion on Auxilium Pharmaceuticals Inc. (AUXL) Sector: Healthcare > Industry: Biotechnology & Drugs
The Name Brand Drug Revolution

Apr 03, 2008 11:15 PM GMT

David Caro-Greene

Return	Risk
-5.40%	MID

Sr. Analyst

Profile & Performance

Subscribe to author

These guys are an in the midst of a major recovery.

I wish I would have had the chance to buy them while they were falling earlier in the year.

Medical is the only business without a market. Each medical IP stock has a virtual lock down on revenues for the length of life of the IP.

These guys are part of the new world order mental landscape painted in pigments and oil bases made of psychotropic chemical substances.

AUXL: This call was made on 04/03/08 @ $29.37

Rating:	$29.37 (04/03/08)
Gain/Loss:	+13.14% in 584 days
Target:	$60.00 (+104.29%) in > one year

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+35.25%	368
2	Gerald Greene	18.14	+70.90%	206
3	stockmarketfunding.com	17.66	+25.78%	53
4	akiralegrand	13.47	+14.32%	60
5	anup2104	12.13	+69.23%	34

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
XOM	Exxon Mobil Corp
EBAY	eBay Inc
BIDU	Baiducom Inc ADS
RIO	Companhia Vale Do Rio Doce
GS	Goldman Sachs Group Inc The
NVDA	NVIDIA Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

EXAS		EXACT Sciences (NASDAQ: EXAS): Buy and Hold for Long-Term Upside by Mike Havrilla
DNDN		New Global Equity Index to Track Immunotherapy, Vaccine Stocks by Mike Havrilla
BNI		Railroad Stocks Steam Ahead on Buffett’s Buy of BNI by Mike Havrilla
PALM		Pixi and beyond. by aitebar82
EVX		Investing in Waste to Energy by Mike Havrilla

... more »

Auxilium Pharmaceuticals Inc. (AUXL)

SocialPicks Sentiment:

This Quarter's Sentiment:

All:

92.5%

Top:

100.0%

Get Daily Email Alerts

Subscribe to David Caro-Greene

Receive Free Ideas Daily for This Sector

Latest Picks by David Caro-Greene

Symbol	SP Sentiment	Return	Since
SYK		+28.50%	04/16/09
MET		+21.93%	04/16/09
PG		-13.33%	10/06/08
JPM		+0.87%	10/06/08
TKTM	N/A	-51.17%	08/31/08

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on Auxilium Pharmaceuticals Inc. (AUXL) Sector: Healthcare > Industry: Biotechnology & Drugs The Name Brand Drug Revolution

Opinion on Auxilium Pharmaceuticals Inc. (AUXL) Sector: Healthcare > Industry: Biotechnology & Drugs
The Name Brand Drug Revolution